Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

    Supports multidisciplinary research teams developing and validating biomarkers for early pancreatic cancer detection and identifying high-risk patients and precursor lesions likely to progress to cancer.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

    The National Cancer Institute seeks applications to establish a management and data coordination unit supporting collaborative research on early pancreatic cancer detection and precursor lesions.

    HHS-NIH11Due Jan 25, 2027$2,500,000

    Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

    Research grant utilizing PLCO bioresources for advancing cancer etiology and early detection biomarkers through biochemical and genetic analyses.

    HHS-NIH11Due Feb 10, 2027

    Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

    This grant funds state, territorial, and tribal organizations to partner on cancer prevention, screening, and control programs, including breast/cervical screening, cancer planning, and cancer registry initiatives.

    HHS-CDC-NCCDPHPForecasted Feb 5, 2027Forecasted

    NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)

    This grant supports centers at institutions with strong existing research in NIDDK-related diseases, funding shared resources, collaboration, mentoring, and pilot programs to advance research in areas like diabetes, obesity, and liver diseases.

    HHS-NIH11Forecasted Jun 1, 2027Forecasted

    Undiagnosed Diseases Network (UDN) Diagnostic Research Innovation Center

    This grant will fund a center to develop and test innovative diagnostic tools for rare and undiagnosed diseases, collaborating with national networks and using advanced genomic and non-genomic approaches.

    HHS-NIH11Forecasted May 25, 2027Forecasted